Avidia — Morgenthaler

New protein structural motifs for treating human disease.

Acquired by Amgen (AMGN)

Links to other Web sites found here are provided to assist you in locating information. Morgenthaler is not responsible for the content of the Web sites found at these links, or beyond, and does not attest to the accuracy, completeness or timeliness of the information they contain. In addition, we have highlighted a select number portfolio companies on a number of our Web pages, but encourage you to review our entire portfolio listed in our Portfolio tabs.

Recent Comments

Archives

Categories

Meta